However, among the patients with cirrhosis, those with HCC had higher levels of circulating RANTES, so this chemokine was proposed as a biomarker for HCC detection in patients with cirrhosis.9 Clearly, the role of RANTES in chronic liver diseases warrants further investigation. The gene discussed is CCL5; the disease is hepatocellular carcinoma.